{"id":3637,"date":"2015-12-17T12:11:53","date_gmt":"2015-12-17T12:11:53","guid":{"rendered":"https:\/\/www.seedcapitalbizkaia.eus\/ganar-la-partida-al-cancer\/"},"modified":"2021-03-15T11:13:57","modified_gmt":"2021-03-15T09:13:57","slug":"ganar-la-partida-al-cancer","status":"publish","type":"post","link":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/","title":{"rendered":"Minbiziaren guda irabazi"},"content":{"rendered":"<h2 style=\"text-align: left;\"><em><strong>2010etik hona, <a href=\"http:\/\/oncomatryx.com\/es\/inicio\/\">Oncomatryx Biopharma<\/a> gogorkiro ari da lanean estroma tumoralaren aurka egingo duen medikamenduaren konposaketan, tratamenduek bete-betean tumorera heldu eta berarekin amaitu dezaten<\/strong><\/em><\/h2>\n<p style=\"text-align: left;\">Tumore batzuk zergatik osatzen dira gaixoen gehiengoan eta beste batzuentzat berriz ez dago tratamendu eraginkorrik? Modu baten edo bestean denok\u00a0 konturatu gara honetaz eta zientifikoek ahalegin handiak egin\u00a0 eta baliabide ugari\u00a0 erabili dituzte gai honetan. Hipotesi nagusietako bat, ebidentzia enpiriko askok babesten dutena, honako hau da: tumoreak osatzen duten zati ezberdinek (zelula motak) harreman zuzena daukate minbizi mota zehatz bat osatzeko tratamenduaren eraginkortasun mailarekin.<\/p>\n<p style=\"text-align: left;\">Ba dago\u00a0 tumore talde bat tumore bera ez diren zelulen hesi batek babestuta garatzen direnak eta zelula horiek, tumorearen hedakuntza errezteaz gain, tratamenduak tumorera erabat heltzea oztopatzen dute: hori da, estroma tumorala deritzona. Hori oinarritzat harturik, 2010ean, Oncomatryx\u00a0 Biopharmak\u00a0 bere jarduerari hasiera eman zion eta bere helburua, estroma tumorala erasotzea zen, tratamenduak tumorera bete-betean heldu eta berarekin amaitu dezaten.<\/p>\n<h3 style=\"text-align: left;\"><strong>Estroma tumorala<\/strong><\/h3>\n<p style=\"text-align: left;\">Estroma tumoralarekin amaitzeko, Oncomatryx\u2013ek\u00a0 antibody-drugconjugates (ADC) deitzen diren zenbait konposatu garatu du. Sorkuntza berriko medikamendu hauek, honako hauek elkartzearen emaitza dira: konposatua gidaria balitz moduan estromaren zelulen barrura bakarrik eramaten duen antigorputza, eta konposatua zelulen barruan dagoenean liberatu eta zelulekin amaitzen duen molekula kimikoa.\u00a0 Konkretuki \u201czelula helburu\u201d mota baten aurka egiten duten elementu hauek erabiltzeak, gaur egungo tratamenduen arazo garrantzitsuetako bat den albo-ondorioak eta\u00a0 toxikotasuna gutxiagotzen du.<\/p>\n<p style=\"text-align: left;\">Urtetan garatu ondoren eta \u201cin vitro\u201d\u00a0 eta \u201c in vivo\u201d ereduetan emaitza bikainak izan eta gero, Oncomatryx gaur egunean, aipatutako horien balidazioa gizakiekin egiteko moduan dago, hori, ezinbesteko urratsa baita tratamendu berri hauek gaixoen eskura normalki\u00a0 jarri ahal izateko. Balidazio kliniko honi hasiera eman ahal izateko, eta gaixoen\u00a0 segurtasunaren mesedetan, agentzia erregulatzaileek medikamendu berri guztiei, zenbait entsegu egitea exijitzen diete, agentzia berberek ezartzen dituzten baldintza zehatz batzuetan: prekliniko erregulatzailea deritzona da.<\/p>\n<h3 style=\"text-align: left;\"><strong>Fase preklinikoa<\/strong><\/h3>\n<p style=\"text-align: left;\">Fase prekliniko erregulatzaileak, zenbait milioi euroko inbertsioa behar du.\u00a0 \u201cGure aurreikuspena, I+D-n,\u00a0 4.500.000 \u20ac-ko\u00a0 gastua egitea\u00a0 da eta hori, gaurdaino inbertitu diren 8.000.000 \u20ac-ei gehitu behar zaio\u201d, adierazi dute Oncomatryx-etik. Enpresak, horren finantziaketari, inbertsore berriek egindako kapital sarreren bidez ekin dio. Zentzu honetan, enpresako arduradunek uste dute, \u201c<a href=\"https:\/\/www.seedcapitalbizkaia.eus\/eu\/\">Seed Capital<\/a>-en ekarria,\u00a0 orain dela hiru urte gertatu zena, bere esperientzia eta\u00a0 zorroztasuna bere baliabideak zein konpainia eta proiektutan sartzea\u00a0 aukeratzerako orduan, funtsezkoa izan da gure enpresarentzat, ez bakarrik zentzu ekonomikoan\u00a0 baizik eta proiektuaren bidegarritasuna eta beste inbertsore potentzialen konfindantza indartzeko orduan ere\u201d.<\/p>\n<p style=\"text-align: left;\">\u201cOncomatryx Biopharma-ren kapital sozialean sartu diren inbertsoreen bidez bermaturik dauden fase prekliniko eta lehen fase klinikoaren garapenerako fondoekin,\u00a0 \u2013adierazi dute-,ematen ari garen urratsek agentzia erregulatzaileen baimena lortzera garamatzate, datozen 18 hilabeteetan gizaki gaixoekin\u00a0 segurtasun eta eraginkortasun frogak hasteko\u201d. \u201cMerkaturako\u201d irteera, gizakiekin\u00a0 entsegu klinikoen fasea amaitzen denean izango da. Oso aldagarria da,\u00a0 baina kalkulu errealista, aipatutako fasea hasi eta 3 edo 5 urte bitartekoa izan daiteke.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2010etik hona, Oncomatryx Biopharma gogorkiro ari da lanean estroma tumoralaren aurka egingo duen medikamenduaren konposaketan, tratamenduek bete-betean tumorera heldu eta berarekin amaitu dezaten Tumore batzuk&#8230;<\/p>\n","protected":false},"author":1,"featured_media":2291,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-3637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-eu"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncomatryx trabaja desde 2010 en combatir los tumores<\/title>\n<meta name=\"description\" content=\"Oncomatryx Biopharma trabaja en la composici\u00f3n de f\u00e1rmacos\u00a0 que combatan el estroma tumoral para que los tratamientos lleguen al tumor plenamente\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"eu_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncomatryx trabaja desde 2010 en combatir los tumores\" \/>\n<meta property=\"og:description\" content=\"Oncomatryx Biopharma trabaja en la composici\u00f3n de f\u00e1rmacos\u00a0 que combatan el estroma tumoral para que los tratamientos lleguen al tumor plenamente\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Seed Capital Bizkaia\" \/>\n<meta property=\"article:published_time\" content=\"2015-12-17T12:11:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-15T09:13:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2015\/12\/laboratorio-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"donostik.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"donostik.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/\"},\"author\":{\"name\":\"donostik.com\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/ddb022041ce4c99790aa462ccfd487d4\"},\"headline\":\"Minbiziaren guda irabazi\",\"datePublished\":\"2015-12-17T12:11:53+00:00\",\"dateModified\":\"2021-03-15T09:13:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/\"},\"wordCount\":443,\"image\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2015\\\/12\\\/laboratorio-scaled.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"eu-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/\",\"name\":\"Oncomatryx trabaja desde 2010 en combatir los tumores\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2015\\\/12\\\/laboratorio-scaled.jpg\",\"datePublished\":\"2015-12-17T12:11:53+00:00\",\"dateModified\":\"2021-03-15T09:13:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/ddb022041ce4c99790aa462ccfd487d4\"},\"description\":\"Oncomatryx Biopharma trabaja en la composici\u00f3n de f\u00e1rmacos\u00a0 que combatan el estroma tumoral para que los tratamientos lleguen al tumor plenamente\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#breadcrumb\"},\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2015\\\/12\\\/laboratorio-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/wp-content\\\/uploads\\\/2015\\\/12\\\/laboratorio-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"oncomatryx trabaja en la lucha contra los tumores\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/ganar-la-partida-al-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minbiziaren guda irabazi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#website\",\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/\",\"name\":\"Seed Capital Bizkaia\",\"description\":\"Seed Capital Bizkaia\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu-ES\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/#\\\/schema\\\/person\\\/ddb022041ce4c99790aa462ccfd487d4\",\"name\":\"donostik.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74ab23f94706a994cd407940c03aad1d070505898936f3d9c9eb1b94919ac449?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74ab23f94706a994cd407940c03aad1d070505898936f3d9c9eb1b94919ac449?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74ab23f94706a994cd407940c03aad1d070505898936f3d9c9eb1b94919ac449?s=96&d=mm&r=g\",\"caption\":\"donostik.com\"},\"sameAs\":[\"https:\\\/\\\/www.seedcapitalbizkaia.eus\"],\"url\":\"https:\\\/\\\/www.seedcapitalbizkaia.eus\\\/eu\\\/author\\\/donostik.com\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncomatryx trabaja desde 2010 en combatir los tumores","description":"Oncomatryx Biopharma trabaja en la composici\u00f3n de f\u00e1rmacos\u00a0 que combatan el estroma tumoral para que los tratamientos lleguen al tumor plenamente","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/","og_locale":"eu_ES","og_type":"article","og_title":"Oncomatryx trabaja desde 2010 en combatir los tumores","og_description":"Oncomatryx Biopharma trabaja en la composici\u00f3n de f\u00e1rmacos\u00a0 que combatan el estroma tumoral para que los tratamientos lleguen al tumor plenamente","og_url":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/","og_site_name":"Seed Capital Bizkaia","article_published_time":"2015-12-17T12:11:53+00:00","article_modified_time":"2021-03-15T09:13:57+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2015\/12\/laboratorio-scaled.jpg","type":"image\/jpeg"}],"author":"donostik.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"donostik.com","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#article","isPartOf":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/"},"author":{"name":"donostik.com","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/ddb022041ce4c99790aa462ccfd487d4"},"headline":"Minbiziaren guda irabazi","datePublished":"2015-12-17T12:11:53+00:00","dateModified":"2021-03-15T09:13:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/"},"wordCount":443,"image":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2015\/12\/laboratorio-scaled.jpg","articleSection":["Noticias"],"inLanguage":"eu-ES"},{"@type":"WebPage","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/","url":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/","name":"Oncomatryx trabaja desde 2010 en combatir los tumores","isPartOf":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2015\/12\/laboratorio-scaled.jpg","datePublished":"2015-12-17T12:11:53+00:00","dateModified":"2021-03-15T09:13:57+00:00","author":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/ddb022041ce4c99790aa462ccfd487d4"},"description":"Oncomatryx Biopharma trabaja en la composici\u00f3n de f\u00e1rmacos\u00a0 que combatan el estroma tumoral para que los tratamientos lleguen al tumor plenamente","breadcrumb":{"@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#breadcrumb"},"inLanguage":"eu-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#primaryimage","url":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2015\/12\/laboratorio-scaled.jpg","contentUrl":"https:\/\/www.seedcapitalbizkaia.eus\/wp-content\/uploads\/2015\/12\/laboratorio-scaled.jpg","width":2560,"height":1707,"caption":"oncomatryx trabaja en la lucha contra los tumores"},{"@type":"BreadcrumbList","@id":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/ganar-la-partida-al-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/"},{"@type":"ListItem","position":2,"name":"Minbiziaren guda irabazi"}]},{"@type":"WebSite","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#website","url":"https:\/\/www.seedcapitalbizkaia.eus\/","name":"Seed Capital Bizkaia","description":"Seed Capital Bizkaia","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seedcapitalbizkaia.eus\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu-ES"},{"@type":"Person","@id":"https:\/\/www.seedcapitalbizkaia.eus\/#\/schema\/person\/ddb022041ce4c99790aa462ccfd487d4","name":"donostik.com","image":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/74ab23f94706a994cd407940c03aad1d070505898936f3d9c9eb1b94919ac449?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/74ab23f94706a994cd407940c03aad1d070505898936f3d9c9eb1b94919ac449?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/74ab23f94706a994cd407940c03aad1d070505898936f3d9c9eb1b94919ac449?s=96&d=mm&r=g","caption":"donostik.com"},"sameAs":["https:\/\/www.seedcapitalbizkaia.eus"],"url":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/author\/donostik.com"}]}},"_links":{"self":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/3637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/comments?post=3637"}],"version-history":[{"count":4,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/3637\/revisions"}],"predecessor-version":[{"id":5308,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/3637\/revisions\/5308"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/media\/2291"}],"wp:attachment":[{"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/media?parent=3637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/categories?post=3637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seedcapitalbizkaia.eus\/eu\/wp-json\/wp\/v2\/tags?post=3637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}